Security News > 2020 > October > COVID-19 Clinical Trials Slowed After Ransomware Attack
A ransomware attack has hit eResearchTechnology, a medical software company that supplies pharma companies with tools for conducting clinical trials - including trials for COVID-19 vaccines.
It hasn't disclosed how many of its customers have been affected by the ransomware attack, or which ransomware strain is responsible.
Pfizer and Johnson & Johnson, both of which are working on a COVID-19 vaccine, announced that their trials weren't impacted by the attack.
While it's unclear what the motivation behind this ransomware attack ultimately was, it's known that attacks on organizations leading the medical fight against the coronavirus pandemic have been continuing.
"Anything connected to sensitive data for COVID-19 is definitely under threat by foreign nation-state actors or foreign competing companies looking to find usable information. Or, it could be an individual attacker or a group of attackers trying to collect money. Attackers understand this has exceptional worth because the companies are very well positioned financially, and that clinical trials make a quick payoff very advantageous."
News URL
https://threatpost.com/covid-19-clinical-trials-ransomware/159877/
Related news
- Kidney dialysis firm DaVita hit by weekend ransomware attack (source)
- Ahold Delhaize confirms data theft after INC ransomware claims attack (source)
- Interlock ransomware gang pushes fake IT tools in ClickFix attacks (source)
- Interlock ransomware claims DaVita attack, leaks stolen data (source)
- Ransomware attacks are getting smarter, harder to stop (source)
- Hitachi Vantara takes servers offline after Akira ransomware attack (source)
- Marks & Spencer breach linked to Scattered Spider ransomware attack (source)
- Ukrainian extradited to US for Nefilim ransomware attacks (source)
- US indicts Black Kingdom ransomware admin for Microsoft Exchange attacks (source)
- Co-op confirms data theft after DragonForce ransomware claims attack (source)